Healthcare Innovation Archives - National Venture Capital Association

NVCA Supports CMS’ Proposed Medicare Coverage Pathway that will Advance Medical Innovation

All Press Releases, Healthcare Innovation, Public Policy November 2, 2020/by Devin Miller

FOR IMMEDIATE RELEASE
November 2, 2020

Contact: Cassie Ann Kiggen
Phone: 202-864-5923
Email: ckiggen@nvca.org

WASHINGTON, DC – The National Venture Capital Association (NVCA) today expressed its strong support to the Centers for Medicare & Medicaid Services’ (CMS) proposal to establish the Medicare Coverage of Innovative Technology (MCIT) pathway. The MCIT would create a new coverage pathway for FDA-designated breakthrough devices, which would significantly improve the complex process of bringing innovative medical products to market. Venture investment in medical devices has decreased as a percentage of overall venture capital. Many medical device investors attribute this decline to the reimbursement landscape.

Trump’s Executive Order on Drug Pricing Could Stymie New Healthcare Solutions

All Press Releases, Healthcare Innovation, Public Policy July 24, 2020/by Devin Miller

FOR IMMEDIATE RELEASE
July 24, 2020

Contact: Cassie Ann Kiggen
Phone: 202-864-5923
Email: ckiggen@nvca.org

WASHINGTON, DC – The National Venture Capital Association (NVCA) today responded to President Trump’s executive order proposing an International Pricing Index, which would tie Medicare’s drug prices to those in other countries.

NVCA Convenes VCs and Policymakers in DC for Annual Meeting

All Press Releases, Capital Formation & Regulation, Healthcare Innovation, Immigration, Taxes May 9, 2017/by actualize

WASHINGTON, DC – The National Venture Capital Association (NVCA) will convene tomorrow venture investors, policymakers and other stakeholders from the entrepreneurial ecosystem for two days of policy discussion and meetings to support new company creation at the NVCA Annual Meeting in Washington, DC.

“We are totally rewriting the script this year for the NVCA Annual Meeting to focus exclusively on policy and direct engagement with policymakers,” said Bobby Franklin, President and CEO of NVCA. “We are bringing VCs to DC to so that the venture community can better understand how policymakers approach our policy issues and in turn how policymakers can better understand how the policies they are working on are impacting new company formation. Read more

NVCA Congratulates Dr. Gottlieb on His Nomination for FDA Commissioner Advancing to Senate

All Press Releases, Healthcare Innovation April 27, 2017/by actualize

WASHINGTON, DC – The National Venture Capital Association (NVCA) issued the following statement today after the Senate Committee on Health, Education, Labor and Pensions (HELP) voted to advance the nomination of Scott Gottlieb, M.D. for Commissioner of the Food and Drug Administration (FDA). A Resident Fellow at the American Enterprise Institute (AEI), Gottlieb has deep experience in the venture industry, previously serving as a venture partner in life sciences startups at New Enterprise Associates (NEA).

“With Dr. Gottlieb’s nomination moving forward to the full Senate for confirmation, the FDA should very soon have a leader in place who has substantial experience and knowledge of the medical innovation ecosystem,” said Bobby Franklin, President and CEO of NVCA. Read more

NVCA Congratulates Dr. Gottlieb on Nomination for FDA Commissioner

All Press Releases, Healthcare Innovation March 13, 2017/by actualize

WASHINGTON, DC – The National Venture Capital Association (NVCA) issued the following statement today in support of the nomination of Scott Gottlieb, M.D. for Commissioner of the Food and Drug Administration (FDA). A Resident Fellow at the American Enterprise Institute (AEI), Gottlieb has deep experience in the venture industry, having previously served as a venture partner in life sciences startups at New Enterprise Associates (NEA).

“Through his experiences in public service, as a practicing physician and as an investor in healthcare startups, Dr. Gottlieb has been on the front lines of medical innovation for decades,” said Bobby Franklin, President and CEO of NVCA. Read more

NVCA Cheers President Obama Signing 21st Century Cures Act into Law

All Press Releases, Healthcare Innovation December 13, 2016/by actualize

WASHINGTON, DC – The National Venture Capital Association (NVCA) today issued the following statement after President Obama signed into law the 21^st Century Cures Act.

“At long last this critical bill is cemented into law after passing both chambers of Congress and signed by the president. Increasing funding for NIH, advancing precision medicine, and improving the environment for the development of life-saving drugs and treatments is critical to ensuring the U.S. remains the tip of the spear in developing breakthrough medical innovation,” said Bobby Franklin, President and CEO of NVCA. Read more

NVCA Outlines Key Policies Priorities in Letter to Donald Trump

All Press Releases, Capital Formation & Regulation, Healthcare Innovation, Immigration, Net Neutrality, Patent Reform, Taxes, Technology December 1, 2016/by actualize

Calls on President-Elect to Commit to Strong Entrepreneurship Agenda

WASHINGTON, DC – In a letter to President-elect Donald J. Trump today, the National Venture Capital Association (NVCA) outlined key policy priorities to strengthen venture capital and the entrepreneurial ecosystem. Recognizing that the Trump campaign for president tapped into a belief that many pockets of the country have been left behind by the modern economy, NVCA called on the president-elect to commit to a strong entrepreneurship agenda as a way to build strong economies in all areas of our country. Read more

NVCA Praises House Passage of 21st Century Cures Act

Healthcare Innovation November 30, 2016/by actualize

Additional Reform Needed to Support Venture Investment in Medical Innovation

WASHINGTON, DC – The National Venture Capital Association (NVCA) today issued the following statement after the House of Representatives passed the 21^st Century Cures Act, sponsored by Rep. Fred Upton (R-MI), Chairman of the House Energy and Commerce Committee, and Energy and Commerce Committee Member Rep. Diana DeGette (D-CO).

“On behalf of our nation’s life science investors who since 2006 have collectively invested over $101 billion into 4,494 companies working on cutting edge medical innovation, we applaud passage in the House today of the 21^st Century Cures Act,” said Bobby Franklin, President and CEO. Read more

NVCA Cheers Provisions Included in Spending and Tax Package that Benefit Entrepreneurial Ecosystem

All Press Releases, Healthcare Innovation, Taxes December 18, 2015/by actualize

WASHINGTON, DC – The National Venture Capital Association (NVCA) today issued the following statement after Congress passed the combined omnibus spending and tax extender package which includes a two-year suspension of the medical device tax and permanence for the 100% exclusion from capital gains taxes for Qualified Small Business Stock (QSBS).

“Since its inception, the medical device tax has been a massive drain on medical device innovation, but has been particularly acute to venture-backed medical device startups due to the imposition of the tax regardless of whether they make a profit or not,” said Bobby Franklin, President and CEO of NVCA. Read more

21st Century Cures Act Will Jumpstart U.S. Medical Innovation

All Press Releases, Healthcare Innovation July 10, 2015/by actualize

WASHINGTON, DC – The National Venture Capital Association (NVCA) today issued the following statement after the House of Representatives overwhelmingly passed H.R. 6, the 21st Century Cures Act of 2015.

“Today’s passage in the House of the 21st Century Cures Act is a huge win for the U.S. medical innovation ecosystem and an example of bipartisanship at work to address some of our nation’s most pressing challenges,” said Bobby Franklin, President and CEO of NVCA. Read more

NVCA Member Spotlight: NGP Capital

blog, Member Spotlight November 20, 2020/by Cassie Ann Kiggen

Welcome to our Member Spotlight series where we give a profile overview of our many diverse members. For this deep dive, we spoke to Monica Johnson, Partner & CFO at NGP Capital.

NVCA Member Spotlight: Insight Partners

blog, Ecosystems, Member Spotlight November 10, 2020/by Cassie Ann Kiggen

Welcome to our Member Spotlight series where we give a profile overview of our many diverse members. For this deep dive, we spoke to Deven Parekh and Hilary Gosher, Managing Directors at Insight Partners.

Calls on President-Elect to Commit to Strong Entrepreneurship Agenda

Additional Reform Needed to Support Venture Investment in Medical Innovation

Stay Connected. Be the first to hear about upcoming initiatives.